Works matching IS 13594184 AND DT 2015 AND VI 20 AND IP 11

Results: 25

Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1479, doi. 10.1038/mp.2015.8

By:

Sidor, M M;
Spencer, S M;
Dzirasa, K;
Parekh, P K;
Tye, K M;
Warden, M R;
Arey, R N;
Enwright, J F;
Jacobsen, J P R;
Kumar, S;
Remillard, E M;
Caron, M G;
Deisseroth, K;
McClung, C A

Publication type:

Article

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1322, doi. 10.1038/mp.2014.123

By:

Lim, Y Y;
Villemagne, V L;
Laws, S M;
Pietrzak, R H;
Snyder, P J;
Ames, D;
Ellis, K A;
Harrington, K;
Rembach, A;
Martins, R N;
Rowe, C C;
Masters, C L;
Maruff, P

Publication type:

Article

Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1386, doi. 10.1038/mp.2014.152

By:

Toulopoulou, T;
van Haren, N;
Zhang, X;
Sham, P C;
Cherny, S S;
Campbell, D D;
Picchioni, M;
Murray, R;
Boomsma, D I;
Pol, H H;
Brouwer, R;
Schnack, H;
Fañanás, L;
Sauer, H;
Nenadic, I;
Weisbrod, M;
Cannon, T D;
Kahn, R S

Publication type:

Article

HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1311, doi. 10.1038/mp.2015.48

By:

Omrani, A;
van der Vaart, T;
Mientjes, E;
van Woerden, G M;
Hojjati, M R;
Li, K W;
Gutmann, D H;
Levelt, C N;
Smit, A B;
Silva, A J;
Kushner, S A;
Elgersma, Y

Publication type:

Article

Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1266, doi. 10.1038/mp.2015.112

By:

Niculescu, A B;
Levey, D F;
Phalen, P L;
Le-Niculescu, H;
Dainton, H D;
Jain, N;
Belanger, E;
James, A;
George, S;
Weber, H;
Graham, D L;
Schweitzer, R;
Ladd, T B;
Learman, R;
Niculescu, E M;
Vanipenta, N P;
Khan, F N;
Mullen, J;
Shankar, G;
Cook, S

Publication type:

Article

Evidence against dopamine D1/D2 receptor heteromers.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1373, doi. 10.1038/mp.2014.166

By:

Frederick, A L;
Yano, H;
Trifilieff, P;
Vishwasrao, H D;
Biezonski, D;
Mészáros, J;
Urizar, E;
Sibley, D R;
Kellendonk, C;
Sonntag, K C;
Graham, D L;
Colbran, R J;
Stanwood, G D;
Javitch, J A

Publication type:

Article

The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1448, doi. 10.1038/mp.2015.104

By:

Sakae, D Y;
Marti, F;
Lecca, S;
Vorspan, F;
Martín-García, E;
Morel, L J;
Henrion, A;
Gutiérrez-Cuesta, J;
Besnard, A;
Heck, N;
Herzog, E;
Bolte, S;
Prado, V F;
Prado, M A M;
Bellivier, F;
Eap, C B;
Crettol, S;
Vanhoutte, P;
Caboche, J;
Gratton, A

Publication type:

Article

Transcriptome organization for chronic alcohol abuse in human brain.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1438, doi. 10.1038/mp.2014.159

By:

Farris, S P;
Arasappan, D;
Hunicke-Smith, S;
Harris, R A;
Mayfield, R D

Publication type:

Article

Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1286, doi. 10.1038/mp.2015.81

By:

Tan, Z;
Dai, W;
van Erp, T G M;
Overman, J;
Demuro, A;
Digman, M A;
Hatami, A;
Albay, R;
Sontag, E M;
Potkin, K T;
Ling, S;
Macciardi, F;
Bunney, W E;
Long, J D;
Paulsen, J S;
Ringman, J M;
Parker, I;
Glabe, C;
Thompson, L M;
Chiu, W

Publication type:

Article

Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1482, doi. 10.1038/mp.2015.117

By:

Toulopoulou, T;
van Haren, N;
Zhang, X;
Sham, P C;
Cherny, S S;
Campbell, D D;
Picchioni, M;
Murray, R;
Boomsma, D I;
Pol, H H;
Brouwer, R;
Schnack, H;
Fañanás, L;
Sauer, H;
Nenadic, I;
Weisbrod, M;
Cannon, T D;
Kahn, R S

Publication type:

Article

Targeting the reconsolidation of extinction memories: a novel potential strategy to treat anxiety disorders.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1264, doi. 10.1038/mp.2015.136

By:

Rosas-Vidal, L E;
Rodriguez-Romaguera, J;
Do-Monte, F H;
Andero, R

Publication type:

Article

Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1350, doi. 10.1038/mp.2014.141

By:

Griesi-Oliveira, K;
Acab, A;
Gupta, A R;
Sunaga, D Y;
Chailangkarn, T;
Nicol, X;
Nunez, Y;
Walker, M F;
Murdoch, J D;
Sanders, S J;
Fernandez, T V;
Ji, W;
Lifton, R P;
Vadasz, E;
Dietrich, A;
Pradhan, D;
Song, H;
Ming, G-l;
Gu, X;
Haddad, G

Publication type:

Article

The 5-HT3 receptor is essential for exercise-induced hippocampal neurogenesis and antidepressant effects.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1428, doi. 10.1038/mp.2014.153

By:

Kondo, M;
Nakamura, Y;
Ishida, Y;
Shimada, S

Publication type:

Article

Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1406, doi. 10.1038/mp.2014.167

By:

Sidor, M M;
Spencer, S M;
Dzirasa, K;
Parekh, P K;
Tye, K M;
Warden, M R;
Arey, R N;
Enwright, J F;
Jacobsen, J P R;
Kumar, S;
Remillard, E M;
Caron, M G;
Deisseroth, K;
McClung, C A

Publication type:

Article

Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1329, doi. 10.1038/mp.2014.170

By:

Chu, J;
Li, J-G;
Giannopoulos, P F;
Blass, B E;
Childers, W;
Abou-Gharbia, M;
Praticò, D

Publication type:

Article

Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1481, doi. 10.1038/mp.2015.43

By:

Li, P.;
Rial, D.;
Canas, P. M.;
Yoo, J.-H.;
Li, W.;
Zhou, X.;
Wang, Y.;
van Westen, G. J. P.;
Payen, M.-P.;
Augusto, E.;
Gonçalves, N.;
Tomé, A. R.;
Li, Z.;
Wu, Z.;
Hou, X.;
Zhou, Y.;
PIJzerman, Ad.;
Boyden, E. S.;
Cunha, R. A.;
Qu, J.

Publication type:

Article

ADAR2-dependent GluA2 editing regulates cocaine seeking.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1460, doi. 10.1038/mp.2014.134

By:

Schmidt, H D;
McFarland, K N;
Darnell, S B;
Huizenga, M N;
Sangrey, G R;
Cha, J-H J;
Pierce, R C;
Sadri-Vakili, G

Publication type:

Article

The phenotypic manifestations of rare genic CNVs in autism spectrum disorder.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1366, doi. 10.1038/mp.2014.150

By:

Merikangas, A K;
Segurado, R;
Heron, E A;
Anney, R J L;
Paterson, A D;
Cook, E H;
Pinto, D;
Scherer, S W;
Szatmari, P;
Gill, M;
Corvin, A P;
Gallagher, L

Publication type:

Article

Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1294, doi. 10.1038/mp.2015.131

By:

Lalli, M A;
Bettcher, B M;
Arcila, M L;
Garcia, G;
Guzman, C;
Madrigal, L;
Ramirez, L;
Acosta-Uribe, J;
Baena, A;
Wojta, K J;
Coppola, G;
Fitch, R;
de Both, M D;
Huentelman, M J;
Reiman, E M;
Brunkow, M E;
Glusman, G;
Roach, J C;
Kao, A W;
Lopera, F

Publication type:

Article

The contribution of rare and common variants in 30 genes to risk nicotine dependence.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1467, doi. 10.1038/mp.2014.156

By:

Yang, J;
Wang, S;
Yang, Z;
Hodgkinson, C A;
Iarikova, P;
Ma, J Z;
Payne, T J;
Goldman, D;
Li, M D

Publication type:

Article

Neurofibromin regulates HCN activity in Parvalbumin-positive interneurons.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1263, doi. 10.1038/mp.2015.154

By:

Omrani, A;
van Woerden, G M;
Elgersma, Y

Publication type:

Article

Acute tianeptine treatment selectively modulates neuronal activation in the central nucleus of the amygdala and attenuates fear extinction.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1420, doi. 10.1038/mp.2014.169

By:

Godsil, B P;
Bontempi, B;
Mailliet, F;
Delagrange, P;
Spedding, M;
Jay, T M

Publication type:

Article

Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1397, doi. 10.1038/mp.2014.171

By:

Arion, D;
Corradi, J P;
Tang, S;
Datta, D;
Boothe, F;
He, A;
Cacace, A M;
Zaczek, R;
Albright, C F;
Tseng, G;
Lewis, D A

Publication type:

Article

p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1301, doi. 10.1038/mp.2015.49

By:

Yao, X-Q;
Jiao, S-S;
Saadipour, K;
Zeng, F;
Wang, Q-H;
Zhu, C;
Shen, L-L;
Zeng, G-H;
Liang, C-R;
Wang, J;
Liu, Y-H;
Hou, H-Y;
Xu, X;
Su, Y-P;
Fan, X-T;
Xiao, H-L;
Lue, L-F;
Zeng, Y-Q;
Giunta, B;
Zhong, J-H

Publication type:

Article

Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory.

Published in:

Molecular Psychiatry, 2015, v. 20, n. 11, p. 1339, doi. 10.1038/mp.2014.182

By:

Li, P;
Rial, D;
Canas, P M;
Yoo, J-H;
Li, W;
Zhou, X;
Wang, Y;
van Westen, G J P;
Payen, M-P;
Augusto, E;
Gonçalves, N;
Tomé, A R;
Li, Z;
Wu, Z;
Hou, X;
Zhou, Y;
PIJzerman, Ad;
Boyden, E S;
Cunha, R A;
Qu, J

Publication type:

Article

Works matching IS 13594184 AND DT 2015 AND VI 20 AND IP 11

Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice.

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.

Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort.

HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.

Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.

Evidence against dopamine D1/D2 receptor heteromers.

The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.

Transcriptome organization for chronic alcohol abuse in human brain.

Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin.

Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort.

Targeting the reconsolidation of extinction memories: a novel potential strategy to treat anxiety disorders.

Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons.

The 5-HT<sub>3</sub> receptor is essential for exercise-induced hippocampal neurogenesis and antidepressant effects.

Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice.

Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice.

Optogenetic activation of intracellular adenosine A<sub>2A</sub> receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory.

ADAR2-dependent GluA2 editing regulates cocaine seeking.

The phenotypic manifestations of rare genic CNVs in autism spectrum disorder.

Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease.

The contribution of rare and common variants in 30 genes to risk nicotine dependence.

Neurofibromin regulates HCN activity in Parvalbumin-positive interneurons.

Acute tianeptine treatment selectively modulates neuronal activation in the central nucleus of the amygdala and attenuates fear extinction.

Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.

p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease.

Optogenetic activation of intracellular adenosine A<sub>2A</sub> receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory.